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Renovascular Hypertension: Factors Affecting the Outcome
Following Surgical Revascularisation
Malik Anas Rabbani, Alia Zaidi, Syed Sohail Ali, Bushra Anas,
Asmooni Younus, Syed Mansoor Ahmad Shah
Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan
ABSTRACT. This study was conducted at the Aga Khan University Hospital, Karachi,
Pakistan to evaluate factors that affect outcome following revascularisation in patients with
renovascular hypertension. We included all the patients diagnosed to have renovascular
hypertension, confirmed by renal angiography, between July 1997 and September 2000. Of
the total 15 patients, nine were males and six were females. Eleven patients received venous
grafts, three received polytetraflouroethyline (PTFE) grafts while one patient underwent
angioplasty and stenting. All were followed-up for a period of nine months (median) with
the range from 2 to 84 months. A total of 33.3% of the study patients were completely
cured, as they became normotensive without anti-hypertensive therapy after operation,
while 27% showed marked improvement in blood pressure control post-operatively. Thus,
extended cure or improvement of renovascular hypertension was achieved in 60% of
patients. Normal pre-operative serum creatinine level, high pre-operative unstimulated
peripheral renin levels and renal vein renin ratio of at least 1.75:1 were the most significant
predictive factors for favorable outcome (p <0.012). The pre-operative severity and
duration of hypertension as well as degree of disparity in kidney sizes did not predict the
post-operative improvement in renal function and blood pressure control.
Key words: Renovascular hypertension, Angiography, Surgical revascularisation,
Renal vein renin ratio, Unstimulated peripheral renin level.
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Introduction
Renovascular hypertension (RVH) is the
most common form of secondary hyper
tension. 1 The exact prevalence of RVH in
the general population is not known and the
diagnosis may be missed in many patients. 2
It is important to diagnose this condition at an
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early stage since it is a potentially curable form
of hypertension, apart from being a potentially
reversible cause of chronic renal failure.
After angioplasty for RVH, about 80% of
patients require less medication for control
of hypertension 3 while in about 48% of
these patients, no anti-hypertensive therapy
is required after the procedure. 4
The major difficulty in curing RVH however,
is identification of the patients with disease.
There are no clinical characteristics that
distinguish patients with RVH from those
with essential hypertension with any degree
of certainty. However, there are several
features that suggest the presence of RVH.
They are:
a) Recent onset of hypertension
b) Age less than 30 or greater than 50 years
c) Accelerated or malignant hypertension
d) Sever hypertensive retinopathy
e) Refractory hypertension
f) Abdominal or flank bruit
The physical sign that correlates best with
the presence of renal artery stenosis is an
abdominal or flank bruit. Approximately twothird of patients have occlusive changes in the
renal arteries due to atherosclerosis and the
remaining one-third have changes due to
fibromuscular dysplasia.
Surgical revascularization is an established
method of treating patients with severe hyper
tension and/or renal insufficiency resulting
from renal artery occlusive disease. With
the availability of effective anti-hypertensive
medications and the use of percutaneous
angioplasty in the treatment of certain patients
with stenotic renal arteries, the role of surgical
treatment has become less clear.

patients diagnosed to have RVH confirmed
by renal angiography between the years 1997
and 2000. Patients with extrinsic compression
of renal arteries or stenosis of renal graft
vessels were excluded.
Record files were reviewed and the following
data were noted: age, sex, clinical presentation,
laboratory investigations including serum
creatinine (SCr), serum electrolytes, ultrasound
of the kidneys, duplex scan, captopril DTPA
scan and conventional angiography. Pre- and
post-operative blood pressure recordings, renal
function and renal and peripheral venous
samples for renin estimation were also
assessed. All the data was analyzed using
SPSS software (Release 8.0, standard version,
copyright c SPSS; 1989-97). Using pairedsample T test, several pre-operative factors
including duration of hypertension at the time
of presentation, renal vein renin ratio (affected
versus non-affected kidney), disparity in
kidney sizes, renal function at the time of
presentation and unstimulated peripheral renin
levels were analyzed for their ability to
predict post-operative improvement of blood
pressure and renal functions.
For descriptive purposes patients were
divided into cured, improved and failure
groups. Cure was defined as normalization of
renal function and blood pressure without
the need for any anti-hypertensive therapy.
Improvement was defined as a >20% decrease
in post-operative SCr and post-operative blood
pressure of less than 160/100 but greater than
140/90 mm Hg. Failure was defined as rise
in SCr of > 20% as compared to pre-operative
levels and blood pressure of >160/100 in
the post-operative phase.
Results

Patients and Methods
This study was conducted at the Aga Khan
University Hospital. It included all the

Demographic features
The clinical and biochemical data from 15
patients with RVH who were subsequently
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operated upon and followed-up for a period
of nine months (median) with a range of 2
to 84 months are summarized in Table 1.
There were nine males and six females. Of
them, 11 patients received vein grafts, three
received polytetraflouroethyline (PTFE) grafts
while one patient underwent angioplasty and
stenting. According to criteria set before
starting the study, five patients were cured,
four showed improvement while six patients
showed no improvement. Thus, nine out of the
15 patients (60%) benefited from the surgical
interventions. The mean age of the cured group
was 45 years (range 15-64 years), 30 years
(range 22-38) in the improved group and 35
years (range 27-52 years) in the failure group.
Renal Function
In the cured group, renal function was normal
in three patients at the time of presentation
while it was abnormal in two patients. Renal
function normalized in one and showed marked
improvement in the other patient, over a period
of nine months.
In the improved group, the SCr was high in
three of the four patients (SCr range 150.3 
344.8 µmol/L) and normal in one patient at the
time of presentation. Of the three patients with
high SCr at presentation, the values normalized
in one patient post-operatively and showed
marked improvement in the other two patients
over the period of follow-up.
Four of the six patients in the failure group
had high SCr at the time of presentation,
(mean 220 µmol/L, range 141.4-221 µmol/L)
and all of them showed further worsening over
a mean period of 17 months. In the remaining
two patients, the renal function was normal
at the time of presentation but deteriorated
over a mean period of four months.
Blood pressure (BP)
The mean pre-operative BP was 183/111 mm
Hg in the cured group, 220/128 mm Hg in
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the improved group and 188/106 mm Hg in
the failure group. The mean duration of hyper
tension in the cured group was 60 months,
in the improved group 74 months and in the
failure group it was 106 months.
Disparity in kidney size
The mean disparity in kidney size in the
cured group was 2.9 cm (range 2-4), in the
improved group it was 2.5 cm and in the
failure group, it was 2.33 cm (range 0.0-4.10).
Renal vein renin ratio (RVRR)
The mean renal vein renin ratio (affected
to non-affected kidney) in the cured group was
3.23:1 (range 2.50-5.50: 1). In the improved
group the ratio was 1.96:1 (range 1.75-2.2: 1)
and in the failure group it was 0.83:1 (range
0.51-1.1: 1).
Peripheral Renin Level
Mean peripheral renin level in the cured
group was 10.72 ng/ml/hr/ (range 8.2-15.5),
in the improved group, 15.2 ng/ml/hr (range
10.0-19.7) and in the failure group it was
5.13 ng/ml/hr (range 4.1-6).
Discussion
Renovascular hypertension is the most
common curable form of high blood pressure.
Several new concepts have emerged in recent
years relative to atherosclerotic renal artery
stenosis. Most notably, the indications for
intervention have changed. 5,6 The enhanced
efficacy of medical anti-hypertensive therapy
has decreased the number of patients who
require intervention solely to treat renovas
cular hypertension.
On the other hand, recent studies of the
natural history of atherosclerotic renal artery
stenosis have shown that progressive vascular
obstruction occurs commonly in patients
treated medically and in most of cases leads
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to deterioration of renal function. 7 This
information has reinforced the importance of
relieving renal arterial obstruction to preserve
renal function in these patients. 7 However,
in some patients with atherosclerotic reno
vascular disease, it is difficult to determine
whether the hypertension is truly renovascular
or the progression of atherosclerosis due to
long standing hypertension caused the renal
artery stenosis. Thus, more extensive investi
gations, particularly in elderly patients, may
be necessary to confirm the renovascular
mechanism of hypertension before surgical
treatment is recommended.
While patients with atherosclerotic renal
artery stenosis were formerly considered high
risk candidates for operative therapy, 8 it has
been demonstrated that surgical revasculari
zation can now be done safely and success
fully even in older patients with extensive
extra-renal vascular disease. 9-11 This has been
accomplished predominately through vigorous
preliminary screening and correction of existing
coronary or cerebrovascular occlusive disease.
In addition, the development of more effective
techniques for surgical revascularization has
made possible operating even on a badly
diseased abdominal aorta. 12
In our study, the long-term clinical outcome
following surgical revascularization in terms
of blood pressure response and post-operative
renal function was evaluated. Extended cure
or improvement of RVH was achieved in
60% of patients with low pre-operative SCr
level, renal vein renin ratio of at least 1.75:1
and high unstimulated peripheral renin
levels all of which constituted significant
predictive factors for the outcome (p <0.012).
Of the 15 patients in the series, 33% were
completely cured, as they became normoten
sive after operation without anti-hypertensive
therapy, while 27% showed marked improve
ment in blood pressure control post-opera
tively needing less medications.
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These results compare favorably to those
of Laurie et al who noted a favorable blood
pressure response to surgical revascularisation
in 82% of 919 patients, followed-up for a
period of six years. 13 However, when both
kidneys are involved the situation becomes
more complex as there is no normal kidney to
excrete the retained sodium and water. In such
patients, the renin and aldosterone levels may
become normal but hypertension persists
because of the increased plasma volume.
In a compilation of 58 different series of
patients, Rudnik et al calculated a sensitivity
of 80% and specificity of 62% for renal vein
renin ratio. 14 Our study has shown that indi
viduals with renal vein renin ratio of at least
1.75:1 have either marked improvement or
complete cure.
Disparity in kidney sizes as well as severity
and duration of hypertension did not affect
the overall post-operative results.
Conclusion
The results of this study confirm the longterm effectiveness and safety of renovas
cular reconstruction in the relief of severe
hypertension. The results further suggest that
normal renal function and renal vein renin
ratio of at least 1.75:1 and high unstimulated
peripheral renin levels at the time of presen
tation are associated with most favorable
post-operative outcome. Pre-operative severity
and duration of hypertension and degree of
disparity in kidney sizes do not seem to
affect the overall results in terms of post
operative improvement in renal function
and blood pressure control.
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